Log in
NASDAQ:NTLA

Intellia Therapeutics SEC Filings & 10K Form

$24.88
+0.07 (+0.28 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$24.12
Now: $24.88
$25.28
50-Day Range
$17.47
MA: $21.89
$26.31
52-Week Range
$9.18
Now: $24.88
$27.07
Volume594,700 shs
Average Volume857,356 shs
Market Capitalization$1.46 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.69

SEC Filings

Intellia Therapeutics (NASDAQ:NTLA) SEC Filings

DateFilerForm TypeView
10/19/2020
7:05 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2020
7:58 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2020
3:14 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2020
3:55 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:15 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
7:23 AM
Intellia Therapeutics (Filer)
Form CT ORDER
08/20/2020
3:30 PM
Intellia Therapeutics (Subject)
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Form SC 13D/A
08/20/2020
3:13 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:29 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2020
3:18 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:10 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:13 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:54 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2020
3:47 PM
Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:46 PM
Intellia Therapeutics (Issuer)
KARSEN PERRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:45 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:44 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:44 PM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:00 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:18 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
4:21 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2020
4:14 PM
Intellia Therapeutics (Filer)
Form 424B5
06/01/2020
3:52 PM
Intellia Therapeutics (Filer)
Form 424B5
06/01/2020
6:13 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2020
4:23 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
3:31 PM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2020
6:47 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2020
5:15 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2020
4:30 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
4:30 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
4:28 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
4:28 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
4:27 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
6:49 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
4:24 PM
Intellia Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G/A
02/12/2020
5:06 AM
Intellia Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
01/09/2020
7:00 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
6:00 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
4:17 PM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2019
6:39 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
4:26 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
11:15 PM
Intellia Therapeutics (Filer)
Form EFFECT
09/10/2019
10:19 AM
FMR LLC (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
08/30/2019
4:13 PM
Intellia Therapeutics (Filer)
Form S-3/A
08/23/2019
4:19 PM
Intellia Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/08/2019
5:02 AM
Intellia Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
08/06/2019
1:19 PM
Intellia Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G/A
08/02/2019
3:15 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
4:16 PM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
6:46 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2019
7:53 AM
Intellia Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G
07/09/2019
5:11 AM
Intellia Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G
06/06/2019
11:15 PM
Intellia Therapeutics (Filer)
Form EFFECT
06/04/2019
3:16 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
3:22 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/22/2019
3:37 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2019
3:36 PM
Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:35 PM
Intellia Therapeutics (Issuer)
KARSEN PERRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:34 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:34 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:33 PM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:32 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
10:57 AM
Intellia Therapeutics (Filer)
Form CT ORDER
05/02/2019
4:00 PM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
7:00 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2019
3:30 PM
Intellia Therapeutics (Filer)
Form DEF 14A
04/05/2019
4:26 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2019
1:19 PM
Caribou Biosciences, Inc. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
03/12/2019
3:38 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
2:15 PM
Intellia Therapeutics (Filer)
Form CT ORDER
03/05/2019
3:36 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
7:40 AM
Intellia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2019
7:37 AM
Intellia Therapeutics (Filer)
Form POS AM
02/27/2019
7:23 AM
Intellia Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2019
6:58 AM
Intellia Therapeutics (Filer)
Form POSASR
02/27/2019
5:52 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
3:02 PM
Intellia Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/11/2019
2:15 PM
Intellia Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/08/2019
5:02 AM
Atlas Venture Fund IX, L.P. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
01/24/2019
4:31 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
4:29 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/24/2019
6:30 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2019
4:29 PM
Caribou Biosciences, Inc. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
01/07/2019
7:48 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2018
3:25 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
3:23 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
3:21 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
3:16 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
3:15 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4/A
12/06/2018
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2018
5:37 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2018
4:58 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2018
4:57 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/31/2018
8:01 AM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2018
6:47 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2018
7:37 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/29/2018
4:10 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2018
4:29 PM
Intellia Therapeutics (Filer)
Form S-3ASR
This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.